| Clinical severity of SARS-CoV-2 omicron variant compared with delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021–2022 N Van Goethem, PYJ Chung, M Meurisse, M Vandromme, L De Mot, ... Viruses 14 (6), 1297, 2022 | 58 | 2022 |
| First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium G Dessilly, L Goeminne, A Vandenbroucke, FE Dufrasne, A Martin, ... PLoS One 13 (12), e0209561, 2018 | 31 | 2018 |
| Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023 E Kissling, M Maurel, HD Emborg, H Whitaker, J McMenamin, J Howard, ... Eurosurveillance 28 (21), 2300116, 2023 | 22 | 2023 |
| Nationwide harmonization effort for semi-quantitative reporting of SARS-CoV-2 PCR test results in Belgium L Cuypers, J Bode, K Beuselinck, L Laenen, K Dewaele, R Janssen, ... Viruses 14 (6), 1294, 2022 | 18 | 2022 |
| Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism FE Dufrasne, M Lucchetti, A Martin, E André, G Dessilly, B Kabamba, ... Virology 513, 11-16, 2018 | 13 | 2018 |
| Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of Congo AT Kabamba, CM Mwamba, G Dessilly, F Dufrasne, BM Kabamba, ... Journal of virological methods 285, 113961, 2020 | 12 | 2020 |
| Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants L Cuypers, S Dellicour, SL Hong, BI Potter, B Verhasselt, N Vereecke, ... Viruses 14 (10), 2301, 2022 | 9 | 2022 |
| Analysis of the involvement of the isoleucine biosynthesis pathway in photoheterotrophic metabolism of Rhodospirillum rubrum G Bayon-Vicente, E Marchand, J Ducrotois, FE Dufrasne, R Hallez, ... Frontiers in Microbiology, 2721, 2021 | 9 | 2021 |
| Single amino acid substitution N659D in HIV-2 envelope glycoprotein (Env) impairs viral release and hampers BST-2 antagonism FE Dufrasne, C Lombard, P Goubau, J Ruelle Viruses 8 (10), 285, 2016 | 9 | 2016 |
| Comprehensive immunovirological and environmental screening reveals risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks L Cuypers, E Keyaerts, S Hong, S Gorissen, SM Menezes, M Starick, ... | 8 | 2022 |
| Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022 MMI Meslé, M Sinnathamby, P Mook, ... Influenza and Other Respiratory Viruses 17 (11), e13219, 2023 | 6 | 2023 |
| Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo AT Kabamba, BT Kalunga, CM Mwamba, CM Nyembo, F Dufrasne, ... Transfusion Clinique et Biologique 28 (1), 30-37, 2021 | 6 | 2021 |
| Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022 AMC Rose, N Nicolay, VS Martín, C Mazagatos, G Petrović, J Baruch, ... Eurosurveillance 28 (47), 2300187, 2023 | 5 | 2023 |
| Severity of infection with the SARS-CoV-2 B. 1.1. 7 lineage among hospitalized COVID-19 patients in Belgium N Van Goethem, M Vandromme, H Van Oyen, F Haarhuis, R Brondeel, ... Plos one 17 (6), e0269138, 2022 | 5 | 2022 |
| Two separate clusters of SARS-CoV-2 delta variant infections in a group of 41 students travelling from India: an illustration of the need for rigorous testing and quarantine J Van Elslande, F Kerckhofs, L Cuypers, E Wollants, B Potter, ... Viruses 14 (6), 1198, 2022 | 5 | 2022 |
| Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024 M Maurel, J Howard, E Kissling, F Pozo, G Pérez-Gimeno, S Buda, ... Eurosurveillance 29 (8), 2400089, 2024 | 3 | 2024 |
| Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha-and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 AMC Rose, N Nicolay, VS Martín, C Mazagatos, G Petrović, FA Niessen, ... Eurosurveillance 28 (47), 2300186, 2023 | 3 | 2023 |
| Study of Viral Load as A Predictive Marker of the Evolution of HIV Type 2 Infection in Burkina Faso JS Mahamoudou Sanou, Absatou Ba /Ky, Assane Neya, Albert T Yonli, François E ... ACTA SCIENTIFIC MICROBIOLOGY 2 (10), 2019 | 3* | 2019 |
| Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS … L Antunes, C Mazagatos, I Martínez-Baz, V Gomez, ML Borg, G Petrović, ... Eurosurveillance 29 (3), 2300708, 2024 | 2 | 2024 |
| Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks L Cuypers, E Keyaerts, SL Hong, S Gorissen, SM Menezes, M Starick, ... Nature aging 3 (6), 722-733, 2023 | 2 | 2023 |
Benoit Kabamba - MukadiProfesseur de virologie, Université Catholique de LouvainVerified email at uclouvain.be
